We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA gave the drug a breakthrough status based on results of a phase 2 study showing the drug plus chemotherapy significantly improved survival for patients. Read More
The SHYCOCAN, which Shreis said can be used alongside handwashing and sanitizing of personal protection equipment, has been granted CE mark certification as a Class I device. Read More
In addition to its pact with GSK, CureVac has also partnered with Novartis and Bayer to potentially manufacture hundreds of millions of doses of CVnCoV. Read More
AroCell believes its test can help in the research of cells as well as the monitoring of therapy response and relapse in patients with hematological and solid tumors. Read More